# Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction

> **NCT00696722** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 16 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus Related Endothelial Dysfunction

## Interventions

- **DRUG:** placebo + atazanavir
- **DRUG:** atazanavir + placebo

## Key facts

- **NCT ID:** NCT00696722
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2010-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696722, "Effects of Atazanavir Treatment on Type 2 Diabetes Mellitus Related Endothelial Dysfunction". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00696722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*